CORONA Remedies Ltd

NSE: CORONA | BSE: 544644

₹1,781.80

up-down-arrow-38.40 (-2.11%)

As on 19-May-2026IST

Market cap

info icon

₹10,893 Cr

Revenue (TTM)

info icon

₹1,196 Cr

P/E Ratio

info icon

58.8

P/B Ratio

info icon

14.6

Div. Yield

info icon

0.6 %

Value Research Rating

Quality Score fund-quick-summary-circle

Quality Score8/10

Growth Score fund-quick-summary-circle

Growth Score7/10

Valuation Score fund-quick-summary-circle

Valuation Score1/10

Momentum Score fund-quick-summary-circle

Momentum ScoreUNRATED/10

CORONA Remedies Share Price

Compare

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 1,776.00 High: 1,864.00

52 Week Range

Low: 1,336.60 High: 1,949.40

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹149 Cr

  • ROEROE information

    27.5 %

  • ROCEROCE information

    32.6 %

  • Industry P/EIndustry P/E information

    26.81

  • EV/EBITDAEV/EBITDA information

    36.1

  • Debt to EquityDebt to Equity information

    0.1

  • Book ValueBook Value information

    ₹99.1

  • EPSEPS information

    ₹24.4

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    61,160,088

5 Years Aggregate

CFO

₹221.86 Cr

EBITDA

₹645.89 Cr

Net Profit

₹394.41 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
CORONA Remedies
28.7 10.0 12.2 -- -- -- --
BSE Healthcare
9.5 9.4 9.8 12.1 27.6 14.5 11.8
As on 19-May-2026
The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
CORONA Remedies
1,781.8 10,892.9 1,196.4 149.4 -- 27.5 58.8 14.6
3,248.2 40,546.6 5,452.9 1,056.0 22.4 23.9 38.4 9.0
8,695.5 21,719.0 2,177.5 200.9 11.3 26.5 108.1 26.1
2,038.2 15,490.4 2,187.2 649.7 31.5 19 24.2 4.3
1,336.2 18,531.3 3,078.2 469.4 26.4 14.9 42.9 5.1
2,171.6 34,908.7 4,147.8 709.5 22.3 18.3 49.2 8.4
4,785.4 21,859.4 2,519.7 722.4 33.6 18.8 30.3 5.2
5,340.5 8,874.7 1,348.5 293.5 28.1 50.7 30.2 12.7
472.5 9,248.1 1,432.0 149.0 19.1 7.9 61.6 3.7
1,153.6 10,633.5 4,858.7 574.1 14.9 19.7 19.1 3.4

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

About CORONA Remedies

--

  • Incorporated

    2004

  • Chairman

    Kirtikumar Laxmidas Mehta

  • Managing Director

    Niravkumar Kirtikumar Mehta

  • Headquarters

    Ahmedabad, Gujarat

  • Website

    www.coronaremedies.com

Edit peer-selector-edit

FAQs for CORONA Remedies

The share price of CORONA Remedies Ltd is ₹1,781.80 (NSE) and ₹1,781.05 (BSE) as of 19-May-2026 IST. CORONA Remedies Ltd has given a return of --% in the last 1 years.

The P/E ratio of CORONA Remedies Ltd is 58.84 times as on 19-May-2026, a 119 premium to its peers’ median range of 26.81 times.
The P/B ratio of CORONA Remedies Ltd is 14.59 times as on 19-May-2026, a 214 premium to its peers’ median range of 4.65 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
0.00
0.00
2024
0.00
0.00
2023
0.00
0.00
2022
0.00
0.00
2021
0.00
0.00

The 52-week high and low of CORONA Remedies Ltd are Rs 1,949.40 and Rs 1,336.60 as of 20-May-2026.

CORONA Remedies Ltd has a market capitalisation of ₹ 10,893 Cr as on 19-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in CORONA Remedies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.